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Clinics 
Age and sex: 25 years old male patient 
Previous History : no preleukemia; no previous 
malignant disease; no inborn condition of note. 
Organomegaly : no hepatomegaly (Negative to 
palpation; Ultrasound not done); no splenomegaly 
(Negative to palpation; Ultrasound not done). 
Blood 
WBC: 19.6 x 109/l; Hb: 12.3 g/dl; platelets: 15x 109/l; 
blasts: 68%; Bone marrow: The specimen was taken 
from the iliac crest and particle crush smears appeared 
cellular but dilute. The trephine imprints were cellular. 
No significant maturation of the myeloid series was 
present. The myeloid series were primarily composed 
of segmented neutrophils. No erythroid dyspoiesis was 
evident. Only a rare magakaryocyte was seen. Blasts 
were similar to those of the peripheral blood and 
appeared very delicate and easily crushed. No Auer 
rods were seen. 
Cytopathology classification 
Cytology: Precursor B-cell acute lymphoblastic 
Leukemia (WHO). 
Immunophenotype: Flow cytometric analysis of the 
marrow was performed at the Methodist Hospital. The 
blasts had a precursor B-lymphoblast phenotype: CD19 
positive, CD20 positive, CD10 positive, CD79a 
positive (cytoplasmic) and TdT positive. Myeloid 
markers (CD13, CD33, CD14, CD117 and 
myeloperoxidase) are negative. T-cell markers (CD3, 
CD5, CD7, CD4 and CD8) are also negative. CD34 is 
positive (partial). 
Rearranged Ig or Tcr: Not done. 
Electron microscopy: Not done. 
Precise diagnosis: Precursor B-cell Acute 
Lymphoblastic Leukemia. 
Survival 
Date of diagnosis: 11-2006 
Treatment: Asparaginase, Cyclophosphamide, 
Daunorubicin, Vineristine. 
Complete remission was obtained. 
Comments: Bone marrow examination on 12-04-2006 
is compatible with early remission. 






Sample: Peripheral Blood; Culture time: 24/48; 
Banding: GTW. 
Results: 46-47, XY,del(5)(q34),t(6;14) 
(p22;q32),i(9)(q10),del(17)(p10),-20,+mar[cp6] 
Other molecular cytogenetic technics: Fluorescence In 
Situ Hybridization (FISH). 
Other molecular cytogenetics results : FISH was 
performed using Vysis LSI IGH dual color, break apart 
rearrangement probe. The analysis revealed an IgH 
rearrangement with the green signal on der (6). 






Atlas Genet Cytogenet Oncol Haematol. 2007;11(2)  153 
 
 
Partial karyotype of case number 06-1570 showing the new t(6;14)(p22;q32) and other anomalies. 
 
Comments 
There are few reports documenting 
t(6;14)(p21.1;q32.3), in cases of multiple 
myeloma/plasma cell leukemia and diffuse large B cell 
non Hodgkin lymphoma. Our case report shows a 
karyotype with multiple abnormalities. One significant 
abnormality observed was the loss of 9 p in the form of 
i(9)(q10), which is a common finding in precursor B-
cell lymphoblastic leukemia. Our case also showed 
partial deletions of 5q and 17p. We observed a novel 
translocation t(6;14) (p22;q32) in a patient with  
Precursor B-cell Acute Lymphoblastic Leukemia. FISH 
studies performed on the metaphases of this specimen 
confirmed the translocation of IGH (located on 
14q32.3). E2F3 is a transcription factor located on 6p22 
that is reported to play a critical role in regulating 
normal cellular proliferation and differentiation. 
Though the exact gene in 6p22 translocation is not yet 
known, it is speculated that E2F3 might be clinically 
significant in leukemia/MDS. However, involvement of 
Geminin, DNA replication inhibitor (GMNN) located 
on 6p22.2 cannot be ruled out. 
  
 
Representative metaphase of case number 06-1570. 
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FISH results showing 14q32 translocation. 
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